Abbott is working with laboratories across the world to leverage their capabilities to enable health systems to meet a sustained rise in chronic illness, increased demand for personalized medicine and changing care models, as well as healthcare staffing shortages by achieving operational efficiency and integrated clinical care excellence.
‘Leverage the Lab for a Higher Performing Health System’ explores these collaborations, and the successes that laboratories have achieved across four key areas: patient care pathways, early disease detection, human resources and staffing and cost savings.
Health systems across the globe are dealing with overcrowding in hospitals, caused by a range of challenges, including diminished hospital capacity and treating growing and aging populations.1 Overcrowding is leading to increased:
Laboratories are helping health systems reduce overcrowding through the implementation of novel patient pathways and increased efficiencies.
Core Diagnostics at Abbott supports laboratories by evaluating their operations to identify opportunities to increase efficiency with a personalized total solution, such as a reduction in patient length of stay.
Undiagnosed disease places an additional burden on already-stretched health systems and on an individual patient’s health. Earlier disease identification and treatment can:3,4
The lack of disease awareness and access to appropriate treatment can impact timely treatment and lead to further disease spread, high morbidity and mortality. Laboratories are supporting earlier detection of disease, in areas such as improved linkage to care.
To increase identification of undiagnosed patients and connection to care, the University of Alabama has rolled out an opt-out program, where emergency department patients are tested for HCV and HIV and guided to appropriate clinical pathways unless they specifically opt-out.
Worldwide, laboratories and health systems are struggling to attract and retain medical technologists.
In an attempt to address these staffing challenges, many systems are paying high levels of overtime costs, hiring contractors and outsourcing work, resulting in higher costs to meet the testing service needs of their clinicians. Abbott is partnering with laboratories to progress performance management, optimising existing staff operations and mitigating unnecessary additional costs.
Streamlining and automating burdensome tasks, such as maintenance and calibration enables staff to dedicate more time to technically demanding activities.
Diagnostic testing volumes are growing across the globe, driven by aging populations and rising prevalence of chronic illness. These demographic trends, when combined with changing care models and reimbursement changes, are causing significant budget challenges:
Laboratories are utilizing Abbott’s end to end solution to drive cost reductions across the health system by reducing operating expenditures.
Abbott is collaborating with laboratories to reduce expenditure by optimizing and automating workflows.
Contact your Representative from Abbott to start formulating a strategic transformation plan that addresses both operational excellence and integrated clinical care in your laboratory.
Learn about the innovative total laboratory automation solution with proven technology and flexibility to meet your goals.
Build key laboratory competencies and explore topics from various disciplines with our learning guides.
Find the latest information in laboratory science, therapeutic areas and Abbott innovation.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
